Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraoperative fluorescence imaging with high-dose indocyanine green for brain and spinal tumors
jRCTs041190064Recruiting
- Sponsor
- Grants-in-Aid for Scientific Research
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of indocyanine green in brain neoplasm and spinal neoplasm, sponsored by Grants-in-Aid for Scientific Research. Primary endpoints: Safety of intraoperative fluorescence imaging with indocyanine green and Postoperative enhancing tumor volume on MRI. Started Nov 2019; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
brain neoplasmspinal neoplasm
Beyond the preview
Go deeper on jRCTs041190064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041190064.